OmniAb (OABI) EBT Margin (2022 - 2026)

OmniAb (OABI) reported EBT Margin of 50.36% for Q1 2026, up 39033.0% year-over-year from N/an in Q1 2025, and up 71.0% quarter-over-quarter from 173.66% in Q4 2025.

OmniAb (OABI) EBT Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of EBT Margin data on file, last reported at 50.36% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 50.36%, up 39033.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 190.93% (up 6385.0% YoY), and the FY2025 annual result was 355.16%, down 8457.0% from the prior year.
  • EBT Margin improved to 50.36% in Q1 2026 per OABI's latest filing, from 173.66% in the prior quarter.
  • Over five years, EBT Margin peaked at 27.27% in Q4 2022 and troughed at 789.91% in Q3 2025.
  • A 5-year average of 279.07% and a median of 215.76% in 2022 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2024 and 2026: EBT Margin slumped 52556 bps in 2024, then surged 39033 bps in 2026.
  • A 5-year view of EBT Margin shows it stood at 27.27% in 2022, then sank by 1623 bps to 415.35% in 2023, then jumped by 66 bps to 140.9% in 2024, then dropped by 23 bps to 173.66% in 2025, then jumped by 71 bps to 50.36% in 2026.
  • Business Quant data shows OABI's EBT Margin at 50.36% in Q1 2026, 173.66% in Q4 2025, and 789.91% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn -50.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 -50.36%
Dec 31, 2025 -173.66%
Sep 30, 2025 -789.91%
Jun 30, 2025 -404.31%
Mar 31, 2025 -440.68%
Dec 31, 2024 -140.90%
Sep 30, 2024 -457.36%
Jun 30, 2024 -203.95%
Mar 31, 2024 -567.69%
Dec 31, 2023 -415.35%
Sep 30, 2023 -347.67%
Jun 30, 2023 -261.50%
Mar 31, 2023 -42.14%
Dec 31, 2022 27.27%
Sep 30, 2022 -215.76%
Jun 30, 2022 -174.55%
Mar 31, 2022 -85.66%